Large Study Finds No Survival Benefit Associated With Removal Of Ovaries
ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer
Study Links Obesity To Higher Risk of Ovarian Cancer
Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line
Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity
Early HER2 Positive Patients At Higher Risk of Recurrence
Tykerb Plus Letrozole Delayed Metastatic Breast Cancer
Estrogen Can Benefit Women With Metastatic Breast Cancer
Alternating Mammography, MRI Tested For High-Risk Women
Degarelix Approved For Advanced Prostate Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”
